Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use
Kristoffer von Stedingk, Katleen De Preter, Jo Vandesompele, Rosa Noguera, Ingrid Øra, Jan Koster, Rogier Versteeg, Sven Påhlman, David Lindgren, Håkan Axelson
